We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, demonstrating strong performance across its business segments.

Abbott Laboratories (NYSE ... This performance was particularly notable given the lower-than-expected Covid testing sales, which were offset by strong showings in other divisions.

They are in a position to begin testing these molecules on human ... by 150 percentage points (see more details here). Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and ...

Abbott Laboratories closed 2024 with an impressive ... This performance was particularly notable given the lower-than-expected Covid testing sales, which were offset by strong showings in other ...

AUSTIN, Texas — Austin’s Silicon Laboratories has received a $23.3 million grant from the Texas Semiconductor Innovation Fund (TSIF), Gov. Greg Abbott announced on Wednesday. The grant will help fund ...

Abbott Laboratories (NYSE:ABT ... which included achieving sales growth of 9.5% excluded COVID testing, delivering 70 basis points of gross margin profile improvement, driving acceleration ...

Capture valuable insights into Abbott Laboratories's market standing by ... diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter ...

The outlook and technical action suggest Abbott Laboratories (NYSE ... in below consensus partly because of weakness in COVID-19 testing, but organic growth is double-digit, and all segments ...

Organic growth, excluding COVID-19 testing-related sales was 10.1% ... single-digit growth for the entire company. Also Read: Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle ...

Abbott Laboratories just extended its dividend growth ... on an organic basis during the fourth quarter. Excluding COVID-19 testing-related sales, ABT's organic sales growth rate was an even ...

This test kit no longer required a patient to ... Some of its current pipeline highlights include: Abbott Laboratories began its 125th year with approximately $22 billion in revenues and ...